Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 402 followers
Latest posts
Last updated about 11 hours ago
How many of these 7 ADC handling considerations are on your radar?
about 11 hours ago
From cytotoxic safety to cold chain control, ADC manufacturing faces new pressures...
Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
about 16 hours ago
With an eye on the lucrative U.S. market, Italy’s Angelini Pharma has...
The timing is right for psychedelics manufacturer Optimi Health's IPO
about 17 hours ago
Last month, when Optimi Health kicked off an initial public offering of...
FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
about 18 hours ago
After a surprise rejection in January, the FDA has agreed to reconsider...
Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
about 20 hours ago
Insulet has always been a strong leader in the medtech industry when...
Alnylam rebuked by FDA over efficacy claims on Amvuttra website
about 23 hours ago
The FDA has hit Alnylam with an untitled letter over the consumer...
Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
1 day ago
The FDA's Commissioner's National Priority Voucher program has been steeped in controversy...
FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
1 day ago
In a bid to better deploy its boots-on-the-ground resources, the FDA is...
Bayer diagnoses how to build trust in cell and gene therapies
1 day ago
Cell and gene therapy developers must build continuity of engagement to create...
Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
1 day ago
After several consecutive quarters on the backfoot, Danish drug juggernaut Novo Nordisk...
FDA blocks publication of COVID, shingles vaccine safety studies: NYT
1 day ago
The FDA-conducted studies reportedly found COVID vaccines and GSK's shingles vaccine Shringrix...
Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
1 day ago
Following a series of “most favored nation” pricing deals with 17 large...